MétaCan
Menu
← Back to cohort
Record W4402164056 · doi:10.1101/2024.09.02.610816

HLA-E and NKG2A Mediate Resistance to BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer

2024· preprint· en· W4402164056 on OpenAlexaff
Daniel Ranti, Haocheng Yu, Bérengère Salomé, Seungmin Bang, Alex Wang, C P Bieber, Trine Strandgaard, Elliot Merritt, G. Doherty, Ashok Narasimhan, Iyinyeoluwa Okulate, Sean Houghton, Jae Ho Kim, Hiranmayi Ravichandran, Achilles A. Demetriou, Z. Li, Sia V. Lindskrog, Dan Fu Ruan, Jorge Daza, Richa Rai, Everardo Hegewisch-Solloa, Emily M. Mace, Ricardo Fernández, Sudeh Izadmehr, A.M. Farkas, Pamela Cruz‐Encarnacion, Sanjana Shroff, F. Patel, Michelle Tran, Daniel Geanon, Geoffrey Kelly, Brian Lee, Kai Nie, Tin Htwe Thin, Mónica Garcı́a-Barros, H. Brown, Benedikt Martin, Alan Soto, Robert Sussman, Sheena Shiwlani, S. Francisco-Simon, Kristin G. Beaumont, YC Wang, Li Wang, Robert Sebra, Steven G. Smith, Mihaela Skobe, Eleanor Clancy‐Thompson, Douglas C. Palmer, Scott A. Hammond, Benjamin D. Hopkins, Peter Wiklund, Jun Zhu, Jose Javier Bravo‐Cordero, Rachel Brody, Zhihong Chen, Seunghee Kim‐Schulze, Lars Dyrskjøt, Olivier Elemento, Anna S. Tocheva, Wengang Song, Nina Bhardwaj, Matthew D. Galsky, John P. Sfakianos, A. Horowitz

Bibliographic record

VenuebioRxiv (Cold Spring Harbor Laboratory) · 2024
Typepreprint
Languageen
FieldMedicine
TopicBladder and Urothelial Cancer Treatments
Canadian institutionsQueen's University
Fundersnot available
KeywordsBladder cancerImmunotherapyCD8ImmunologyCancer researchImmune systemMedicinePD-L1Cytotoxic T cellCancerBiologyInternal medicine

Abstract

fetched live from OpenAlex

ABSTRACT Background Bacillus Calmette-Guérin (BCG) is the standard of care treatment for high-risk non-muscle-invasive bladder cancer (NMIBC), yet many patients develop recurrent disease despite evidence of ongoing immune activation. We investigated mechanisms of immune escape in BCG-unresponsive tumors and evaluated the therapeutic potential of targeting the HLA-E/NKG2A axis. Methods Single-cell RNA sequencing, spatial immunophenotyping, proteomic profiling, and functional ex vivo assays were performed using tumors and urine samples from patients with BCG-naïve and BCG-unresponsive NMIBC. Results BCG-unresponsive tumors were enriched for HLA-E-expressing malignant cells compared with BCG-naïve tumors. Increased HLA-E expression was associated with enhanced IFN-γ signaling and was induced by IFN-γ stimulation in primary tumor cells and bladder cancer tumor lines. Spatial analyses demonstrated accumulation of NKG2A + NK and CD8 T cells in proximity to HLA-E high tumor cells, with increased NKG2A:HLA-E interactions in BCG-unresponsive tumors. Despite high expression of cytotoxic mediators, NKG2A + effector cells displayed impaired degranulation. Blockade of NKG2A with monalizumab restored degranulation of and cytotoxicity by tumor-infiltrating lymphocytes in autologous tumor co-cultures. Conclusions BCG-unresponsive NMIBC tumors are enriched for HLA-E-expressing tumor cells and NKG2A + effector lymphocytes, with increased engagement of the HLA-E/NKG2A axis within the tumor microenvironment. These findings identify the HLA-E/NKG2A axis as a therapeutic vulnerability and provide a rationale for clinical evaluation of NKG2A blockade as a bladder-sparing strategy for patients with BCG-unresponsive disease.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.259
Teacher spread0.247 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2024
Admission routes1
Has abstractyes

Explore more

Same venuebioRxiv (Cold Spring Harbor Laboratory)→Same topicBladder and Urothelial Cancer Treatments→French-language works237,207→